全球幽门螺旋桿菌诊断市场规模、份额、趋势和成长分析报告（2026-2034）

预计幽门螺旋桿菌诊断市场将从 2025 年的 7.6237 亿美元成长到 2034 年的 13.023 亿美元，2026 年至 2034 年的复合年增长率为 6.13%。

由于全球胃部感染疾病、溃疡和胃癌的盛行率不断上升，全球幽门螺旋桿菌诊断市场正经历稳定成长。人们对早期诊断和预防医学的认识不断提高，促使检测量增加。呼吸检测和粪便抗原检测等非侵入性诊断方法的日益普及进一步推动了市场扩张。此外，新兴经济体医疗基础设施的改善也使人们更容易获得先进的诊断服务。

关键成长要素包括诊断试剂盒的技术进步、医疗费用支出增加以及政府支持的筛检项目。医院和诊断检查室对准确快速的诊断解决方案的需求日益增长。生活方式的改变、不健康的饮食习惯以及胃肠道疾病病例的增加也促进了检测量的增长。此外，分子诊断技术的整合提高了检测的准确性，并推动了检测方法的普及。

展望未来，在就地检验和个人化医疗方法持续创新的推动下，市场预计将稳定成长。医疗保险覆盖范围的扩大和对预防医学的日益重视将创造新的机会。由于健康意识的提高和医疗设施的改善，亚太和拉丁美洲等新兴市场的需求预计将十分强劲。整体而言，随着早期检测成为全球医疗保健策略的重中之重，市场前景仍然光明。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球幽门螺旋桿菌诊断市场：按类型划分

• 市场分析、洞察与预测
• 装置
• 试剂
• 服务

第五章 全球幽门螺旋桿菌诊断市场：依技术划分

• 市场分析、洞察与预测
• 免疫检测
• POC
• 分子诊断

第六章 全球幽门螺旋桿菌诊断市场：依最终使用者划分

• 市场分析、洞察与预测
• 医院
• 诊断检查室
• 诊所

第七章 全球幽门螺旋桿菌诊断市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Thermo Fisher Scientific
  • Biohit Oyj
  • Quest Diagnostics Incorporated
  • Meridian Bioscience
  • Bio-Rad Laboratories
  • Alpha Laboratories Ltd
  • F. Hoffmann-La Roche Ltd
  • Coris BioConcept
  • Certest Biotec
  • Epitope Diagnostics Inc

The Helicobacter Pylori Diagnostics Market size is expected to reach USD 1302.30 Million in 2034 from USD 762.37 Million (2025) growing at a CAGR of 6.13% during 2026-2034.

The Global Helicobacter Pylori Diagnostics Market is witnessing steady growth due to the rising prevalence of gastric infections, ulcers, and stomach cancer worldwide. Increasing awareness about early diagnosis and preventive healthcare is encouraging more people to undergo testing. The growing availability of non-invasive diagnostic methods, such as breath tests and stool antigen tests, has further supported market expansion. In addition, improved healthcare infrastructure in emerging economies is boosting access to advanced diagnostic services.

Key growth drivers include technological advancements in diagnostic kits, rising healthcare spending, and supportive government screening programs. The demand for accurate and rapid diagnostic solutions is increasing among hospitals and diagnostic laboratories. Lifestyle changes, poor dietary habits, and increasing cases of gastrointestinal disorders are also contributing to higher testing volumes. Moreover, the integration of molecular diagnostic techniques is enhancing detection accuracy and driving adoption.

Looking ahead, the market is expected to grow consistently with continuous innovation in point-of-care testing and personalized medicine approaches. Expanding healthcare coverage and increasing focus on preventive care will create new opportunities. Emerging markets in Asia-Pacific and Latin America are likely to witness strong demand due to improving awareness and medical facilities. Overall, the future outlook remains positive as early detection becomes a priority in global healthcare strategies.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Instruments
• Reagents
• Services

By Technology

• Immunoassays
• POC
• Molecular Diagnostics

By End-user

• Hospitals
• Diagnostics Laboratories
• Clinics

COMPANIES PROFILED

• Thermo Fisher Scientific, Biohit Oyj, Quest Diagnostics Incorporated, Meridian Bioscience, BioRad Laboratories, Alpha Laboratories Ltd, F HoffmannLa Roche Ltd, Coris BioConcept, Certest Biotec, Epitope Diagnostics Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Immunoassays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. POC Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Molecular Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostics Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Technology
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Technology
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Technology
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Technology
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Technology
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HELICOBACTER PYLORI DIAGNOSTICS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Thermo Fisher Scientific
  • 9.2.2 Biohit Oyj
  • 9.2.3 Quest Diagnostics Incorporated
  • 9.2.4 Meridian Bioscience
  • 9.2.5 Bio-Rad Laboratories
  • 9.2.6 Alpha Laboratories Ltd
  • 9.2.7 F. Hoffmann-La Roche Ltd
  • 9.2.8 Coris BioConcept
  • 9.2.9 Certest Biotec
  • 9.2.10 Epitope Diagnostics Inc